176 related articles for article (PubMed ID: 11502514)
1. In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.
Kanamaru T; Nakano Y; Toyoda Y; Miyagawa KI; Tada M; Kaisho T; Nakao M
Antimicrob Agents Chemother; 2001 Sep; 45(9):2455-9. PubMed ID: 11502514
[TBL] [Abstract][Full Text] [Related]
2. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
[TBL] [Abstract][Full Text] [Related]
4. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
Koga T; Inoue H; Ishii C; Okazaki Y; Domon H; Utsui Y
J Antimicrob Chemother; 2002 Jul; 50(1):133-6. PubMed ID: 12096020
[TBL] [Abstract][Full Text] [Related]
5. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria.
Ani AE; Malu AO; Onah JA; Queiroz DM; Kirschner G; Rocha GA
Trans R Soc Trop Med Hyg; 1999; 93(6):659-61. PubMed ID: 10717760
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anti- Helicobacter pylori activity of Y-904, a new fluoroquinolone.
Iwao E; Yokoyama Y; Yamamoto K; Hirayama F; Haga K
J Infect Chemother; 2003 Jun; 9(2):165-71. PubMed ID: 12825117
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance of Helicobacter pylori.
Kusters JG; Kuipers EJ
Symp Ser Soc Appl Microbiol; 2001; (30):134S-44S. PubMed ID: 11422569
[No Abstract] [Full Text] [Related]
9. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
Ogata SK; Godoy AP; da Silva Patricio FR; Kawakami E
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):645-8. PubMed ID: 23403439
[TBL] [Abstract][Full Text] [Related]
10. Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi.
Lwai-Lume L; Ogutu EO; Amayo EO; Kariuki S
East Afr Med J; 2005 Dec; 82(12):603-8. PubMed ID: 16619703
[TBL] [Abstract][Full Text] [Related]
11. Amoxicillin for the treatment of Helicobacter pylori infection.
Hirschl AM; Rotter ML
J Gastroenterol; 1996 Nov; 31 Suppl 9():44-7. PubMed ID: 8959518
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
Yan WH; Chen J; Hu HJ; Yu JD; Huang XL; Li ZY
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):708-11. PubMed ID: 18021568
[TBL] [Abstract][Full Text] [Related]
13. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
Schütze K; Hentschel E; Hirschl AM
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):41-6. PubMed ID: 8900907
[TBL] [Abstract][Full Text] [Related]
14. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy].
Tsuneoka H; Takaba M; Nagatomi Y; Mori K; Matsumoto T; Honda T
Kansenshogaku Zasshi; 1998 Apr; 72(4):335-41. PubMed ID: 9621560
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland.
Karczewska E; Wojtas-Bonior I; Sito E; Zwolińska-Wcisło M; Budak A
Pharmacol Rep; 2011; 63(3):799-807. PubMed ID: 21857091
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole.
Blacky A; Makristathis A; Apfalter P; Willinger B; Rotter ML; Hirschl AM
Eur J Clin Microbiol Infect Dis; 2005 Apr; 24(4):276-9. PubMed ID: 15902535
[TBL] [Abstract][Full Text] [Related]
18. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
19. High incidence of antibiotic resistance amongst isolates of
Garvey E; Rhead J; Suffian S; Whiley D; Mahmood F; Bakshi N; Letley D; White J; Atherton J; Winter JA; Robinson K
J Med Microbiol; 2023 Nov; 72(11):. PubMed ID: 37962209
[No Abstract] [Full Text] [Related]
20. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Fakheri H; Malekzadeh R; Merat S; Khatibian M; Fazel A; Alizadeh BZ; Massarrat S
Aliment Pharmacol Ther; 2001 Mar; 15(3):411-6. PubMed ID: 11207517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
